Atomoxetine is a selective norepinephrine (NE) reuptake inhibitor approved for the treatment
of attention-deficit/hyperactivity disorder (ADHD) in children (≥ 6 years of age), adolescents …

ABSTRACT ADHD is a disability characterised by hyperactivity, impulsivity and difficulties
maintaining attention. Despite extensive research on ADHD, the effects of existing …

Children/adolescents with attention-deficit/hyperactivity disorder (ADHD) may have a poor or
inadequate response to psychostimulants or be unable to tolerate their side-effects; …

This study aimed to determine the effects of psychodrama-based group therapy on reducing
aggression, social anxiety, and attention-deficit/hyperactivity disorder (ADHD) symptoms in …

Background Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral
disorder affecting approximately 10.0% of children and 6.5% of adolescents in the United …

Objective: To examine ADHD symptom persistence and subtype stability among substance
use disorder (SUD) treatment seekers. Method: In all, 1,276 adult SUD treatment seekers …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder
beginning in childhood and often persisting into adulthood with an estimated worldwide …

Objective: ADHD and asthma are prevalent conditions in childhood, with complex
pathophysiology involving genetic-environmental interplay. The study objective is to …

The study compares the effectiveness of long-term psychoanalytic psychotherapy without
medication with behavioral therapy and/or medication treatment. Seventy-three children with …

Background Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and
pharmacotherapy is the mainstay of treatment, with a variety of ADHD medications available …